Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nicardipine Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : NeuroScios | Data Magik | pharm-analyt Labor
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Nicardipine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Subarachnoid Hemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 13, 2020
Lead Product(s) : Nicardipine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : NeuroScios | Data Magik | pharm-analyt Labor
Deal Size : Inapplicable
Deal Type : Inapplicable